- Meeting abstract
- Open Access
Development of XMRV producing B Cell lines from lymphomas from patients with Chronic Fatigue Syndrome
Retrovirology volume 8, Article number: A230 (2011)
Previous studies have shown that CFS patients have an increased incidence of lympho-proliferative malignancy compared to the normal population . While the incidence rate of non-Hodgkin’s lymphoma in the United States is 0.02%, nearly 5% of the CFS patients developed the disease. Additionally, development of cancer coincides with an outgrowth of gamma delta T cells with specific clonal T-cell receptor gamma rearrangements. We hypothesized that infection with XMRV and/or other viruses can trigger a dysregulated immune response which favors the development of B-cell lymphoma.
In a study of 300 CFS patients, 13 developed lymphoproliferative disorders. Of those tested, 11/11 were positive for XMRV and 9/9 positive for clonal TCR gamma rearrangements. Spontaneous development of four B cells lines occurred during culture of cells from CFS patients. Three developed from B cells isolated from the peripheral blood (two of whom had B cell lymphoma) and one from a bone marrow biopsy. For all four lines, the B cells have a mature CD20+, CD23+ phenotype and produce infectious XMRV at a titer of >106 infectious units/ml. Virus production occurred despite extensive hypermutation of the proviruses in these cells by APOBEC3G.. Therefore XMRV infection may accelerate the development of B cell malignancies by either indirect chronic stimulation of the immune system and/or by direct infection of the B-cell lineage . Since viral load in peripheral blood is low, these data suggest that B cells in tissues such as spleen and lymph nodes could be an in vivo reservoir for XMRV.
Fears TR, Cummings P, Hoover RN: Cancer and a fatiguing illness in Northern Nevada: a causal hypothesis. Ann Epidemiol. 1998, 8: 245-249. 10.1016/S1047-2797(97)00203-2.
About this article
Cite this article
Ruscetti, F., Lombardi, V.C., Snyderman, M. et al. Development of XMRV producing B Cell lines from lymphomas from patients with Chronic Fatigue Syndrome. Retrovirology 8, A230 (2011) doi:10.1186/1742-4690-8-S1-A230
- Chronic Fatigue Syndrome
- Bone Marrow Biopsy
- Lymphoproliferative Disorder
- Receptor Gamma